... This strong cash position now enables us to purchase the new modern R&D Lab and cGMP Clinical Production facility in Shelton, CT, without affecting any of our developmental programs including FluCide and DengueCide, or any of our R&D programs, ...
via Shelton Newswire http://ift.tt/1tlQvbk
via Shelton Newswire http://ift.tt/1tlQvbk
No comments:
Post a Comment